pfizer glp 1 drug The next breakthrough in weight-loss medicine may not be a stronger drug. It may simply be a people are more likely to keep taking. Pfizer's experimental obesity treatment, berobenatide, could reduce China approves Pfizer GLP-1 drug

For anyone exploring neuroprotective peptide strategies , understanding the BDNF-neurodegeneration connection is foundational

Although they eliminate some combustion-derived toxins, they still deliver harmful substances capable of inducing oxidative stress, mitochondrial dysfunction, inflammation, and hepatocellular injury

Dopamine-derived quinones (DA-Q) can undergo intramolecular cyclization and oxidation to form leukochrome, aminochrome, and finally, neuromelanin, a pigment involved in neuroinflammation and neurodegeneration (Zecca et al

J Clin Invest 128:33413355 Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis

Despite mounting evidence of this connection, Novo Nordisks current warning labels for Ozempic and Wegovy do not list NAION as a specific risk, mentioning only general vision changes among potential risks a disclosure many patients and legal experts argue falls far short of adequate warning about permanent blindness